| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.719 | 0.007 | 0.719 | Antibacterial | 0.3 0.136 DBMET00640 | ||
| 0.668 | 0.005 | 0.668 | DNA synthesis inhibitor | 0.421 0.019 DBMET00640 | ||
| 0.662 | 0.004 | 0.662 | Topoisomerase II inhibitor | |||
| 0.484 | 0.003 | 0.484 | DNA gyrase inhibitor | |||
| 0.378 | 0.002 | 0.378 | DNA topoisomerase IV inhibitor | |||
| 0.339 | 0.088 | 0.339 | Toll-Like receptor 7 agonist | |||
| 0.334 | 0.09 | 0.334 | Toll-Like receptor agonist | |||
| 0.356 | 0.118 | 0.356 | Cyclophilin D inhibitor | |||
| 0.141 | 0.003 | 0.141 | DNA gyrase subunit A inhibitor | |||
| 0.158 | 0.059 | 0.26 | Cell wall synthesis inhibitor | 0.26 0.014 DBMET00640 | DBMET00640 | |
| 0.07 | 0.006 | 0.07 | DNA gyrase subunit B inhibitor | |||
| 0.055 | 0.017 | 0.055 | Guanylate cyclase stimulant | |||
| 0.08 | 0.042 | 0.08 | Protein kinase B beta inhibitor | |||
| 0.06 | 0.022 | 0.06 | Topoisomerase II beta inhibitor | |||
| 0.088 | 0.061 | 0.088 | Pim-3 kinase inhibitor | |||
| 0.055 | 0.028 | 0.055 | Antiviral (Hepatitis D) | |||
| 0.088 | 0.065 | 0.088 | Hepatocyte growth factor antagonist | |||
| 0.132 | 0.111 | 0.132 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.045 | 0.029 | 0.045 | Dipeptidyl peptidase IV inhibitor | |||
| 0.166 | 0.153 | 0.166 | Interleukin agonist | |||
| 0.065 | 0.057 | 0.065 | HIV-1 integrase inhibitor | |||
| 0.02 | 0.013 | 0.02 | Guanylate cyclase 1 stimulant | |||
| 0.134 | 0.132 | 0.134 | Lipocortins synthesis antagonist | |||
| 0.077 | 0.1 | 0.265 | GABA C receptor agonist | 0.265 0.012 DBMET00640 | DBMET00640 | |
| 0.24 | 0.305 | 0.355 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.355 0.146 DBMET00640 | DBMET00640 | |
| 0.029 | 0.124 | 0.046 | Dopamine beta hydroxylase inhibitor | 0.046 0.039 DBMET00640 | DBMET00640 | |
| 0.018 | 0.133 | 0.068 | Cholecystokinin B agonist | 0.068 0.01 DBMET00640 | DBMET00640 | |
| 0.002 | 0.202 | 0.014 | Glutamate (mGluR6) agonist | 0.014 0.007 DBMET00640 | DBMET00640 | |
| 0.073 | 0.284 | 0.108 | DNA repair enzyme inhibitor | 0.108 0.101 DBMET00640 | DBMET00640 | |
| 0.014 | 0.231 | 0.103 | Purinergic P2Y2 antagonist | 0.103 0.004 DBMET00640 | DBMET00640 | |
| 0.017 | 0.234 | 0.042 | Glutamate (mGluR8) agonist | 0.042 0.019 DBMET00640 | DBMET00640 | |
| 0.013 | 0.232 | 0.058 | HIV-1 integrase (Strand Transfer) inhibitor | 0.058 0.043 DBMET00640 | DBMET00640 | |
| 0.05 | 0.279 | 0.112 | DOPA decarboxylase inhibitor | 0.112 0.055 DBMET00640 | DBMET00640 | |
| 0.046 | 0.278 | 0.942 | Protein-tyrosine phosphatase inhibitor | 0.942 0.001 DBMET00640 | DBMET00640 | |
| 0.018 | 0.253 | 0.063 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.063 0.006 DBMET00640 | DBMET00640 | |
| 0.039 | 0.275 | 0.102 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.102 0.052 DBMET00640 | DBMET00640 | |
| 0.017 | 0.255 | 0.087 | Purinergic P2X2 antagonist | 0.087 0.036 DBMET00640 | DBMET00640 | |
| 0.008 | 0.249 | 0.046 | Guanylate cyclase inhibitor | 0.046 0.025 DBMET00640 | DBMET00640 | |
| 0.013 | 0.26 | 0.062 | Argininosuccinate synthase inhibitor | 0.062 0.035 DBMET00640 | DBMET00640 | |
| 0.096 | 0.343 | 0.208 | 5 Hydroxytryptamine release stimulant | 0.208 0.115 DBMET00640 | DBMET00640 | |
| 0.101 | 0.348 | 0.156 | Ca2+-transporting ATPase inhibitor | 0.156 0.03 DBMET00640 | DBMET00640 | |
| 0.048 | 0.296 | 0.366 | Angiogenesis stimulant | 0.366 0.028 DBMET00640 | DBMET00640 | |
| 0.005 | 0.267 | 0.033 | Purinergic P2X agonist | 0.033 0.016 DBMET00640 | DBMET00640 | |
| 0.034 | 0.327 | 0.113 | GABA C receptor rho-1 antagonist | 0.113 0.046 DBMET00640 | DBMET00640 | |
| 0.022 | 0.319 | 0.092 | Alcohol dehydrogenase inhibitor | 0.092 0.061 DBMET00640 | DBMET00640 | |
| 0.026 | 0.326 | 0.15 | Glutamate dehydrogenase inhibitor | 0.15 0.016 DBMET00640 | DBMET00640 | |
| 0.014 | 0.317 | 0.065 | Aconitate hydratase inhibitor | 0.065 0.022 DBMET00640 | DBMET00640 | |
| 0.105 | 0.409 | 0.19 | Nitric-oxide synthase stimulant | 0.19 0.107 DBMET00640 | DBMET00640 | |
| 0.03 | 0.34 | 0.071 | Glutamate (mGluR6) antagonist | 0.071 0.038 DBMET00640 | DBMET00640 | |
| 0.028 | 0.341 | 0.227 | GABA C receptor antagonist | 0.227 0.009 DBMET00640 | DBMET00640 | |
| 0.116 | 0.447 | 0.26 | 5 Hydroxytryptamine uptake stimulant | 0.26 0.072 DBMET00640 | DBMET00640 | |
| 0.004 | 0.347 | 0.034 | Glutamate (mGluR1a) agonist | 0.034 0.007 DBMET00640 | DBMET00640 | |
| 0.01 | 0.363 | 0.082 | Biliverdin reductase inhibitor | 0.082 0.025 DBMET00640 | DBMET00640 | |
| 0.009 | 0.364 | 0.173 | Phosphofructokinase-1 inhibitor | 0.173 0.014 DBMET00640 | DBMET00640 | |
| 0.013 | 0.38 | 0.066 | CDC25A inhibitor | 0.066 0.064 DBMET00640 | DBMET00640 | |
| 0.022 | 0.397 | 0.181 | Creatine kinase inhibitor | 0.181 0.014 DBMET00640 | DBMET00640 | |
| 0.037 | 0.414 | 0.254 | Anticonvulsant | 0.254 0.056 DBMET00640 | DBMET00640 | |
| 0.012 | 0.393 | 0.123 | Phenylalanine 4-hydroxylase inhibitor | 0.123 0.017 DBMET00640 | DBMET00640 | |
| 0.016 | 0.397 | 0.079 | Phospholipase D inhibitor | 0.079 0.037 DBMET00640 | DBMET00640 | |
| 0.023 | 0.405 | 0.191 | Ferrochelatase inhibitor | 0.191 0.025 DBMET00640 | DBMET00640 | |
| 0.008 | 0.393 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.01 DBMET00640 | DBMET00640 | |
| 0.041 | 0.427 | 0.233 | Adenylate kinase inhibitor | 0.233 0.011 DBMET00640 | DBMET00640 | |
| 0.004 | 0.391 | 0.07 | Kainate receptor antagonist | 0.07 0.012 DBMET00640 | DBMET00640 | |
| 0.031 | 0.418 | 0.203 | NADH dehydrogenase inhibitor | 0.203 0.01 DBMET00640 | DBMET00640 | |
| 0.018 | 0.408 | 0.112 | Urease inhibitor | 0.112 0.054 DBMET00640 | DBMET00640 | |
| 0.005 | 0.4 | 0.189 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.189 0.004 DBMET00640 | DBMET00640 | |
| 0.011 | 0.409 | 0.136 | Glutamate decarboxylase inhibitor | 0.136 0.016 DBMET00640 | DBMET00640 | |
| 0.018 | 0.416 | 0.133 | Macrophage migration inhibitory factor inhibitor | 0.133 0.021 DBMET00640 | DBMET00640 | |
| 0.008 | 0.41 | 0.062 | Mannosidase inhibitor | 0.062 0.016 DBMET00640 | DBMET00640 | |
| 0.011 | 0.416 | 0.06 | AICAR transformylase inhibitor | 0.06 0.014 DBMET00640 | DBMET00640 | |
| 0.026 | 0.432 | 0.345 | Alpha-N-acetylglucosaminidase inhibitor | 0.345 0.012 DBMET00640 | DBMET00640 | |
| 0.022 | 0.429 | 0.137 | UDP-glucose 4-epimerase inhibitor | 0.137 0.034 DBMET00640 | DBMET00640 | |
| 0.057 | 0.466 | 0.506 | Angiogenesis inhibitor | 0.506 0.029 DBMET00640 | DBMET00640 | |
| 0.027 | 0.437 | 0.228 | Triose-phosphate isomerase inhibitor | 0.228 0.008 DBMET00640 | DBMET00640 | |
| 0.104 | 0.516 | 0.263 | 5 Hydroxytryptamine release inhibitor | 0.263 0.211 DBMET00640 | DBMET00640 | |
| 0.076 | 0.495 | 0.27 | Cyclin-dependent kinase 3 inhibitor | 0.27 0.013 DBMET00640 | DBMET00640 | |
| 0.004 | 0.424 | 0.088 | Ornithine carbamoyltransferase inhibitor | 0.088 0.019 DBMET00640 | DBMET00640 | |
| 0.02 | 0.443 | 0.385 | Aminoacyl-tRNA synthetase inhibitor | 0.385 0.004 DBMET00640 | DBMET00640 | |
| 0.025 | 0.449 | 0.117 | HIV-1 integrase (Overall Integration) inhibitor | 0.117 0.041 DBMET00640 | DBMET00640 | |
| 0.003 | 0.436 | 0.035 | Fumarate hydratase inhibitor | 0.035 0.023 DBMET00640 | DBMET00640 | |
| 0.065 | 0.505 | 0.141 | Neurotensin receptor agonist | 0.141 0.124 DBMET00640 | DBMET00640 | |
| 0.01 | 0.451 | 0.218 | Porphobilinogen synthase inhibitor | 0.218 0.01 DBMET00640 | DBMET00640 | |
| 0.02 | 0.468 | 0.16 | Aminopeptidase B inhibitor | 0.16 0.033 DBMET00640 | DBMET00640 | |
| 0.018 | 0.467 | 0.09 | Cystathionine beta-synthase inhibitor | 0.09 0.089 DBMET00640 | DBMET00640 | |
| 0.021 | 0.473 | 0.096 | Glycine receptor agonist | 0.096 0.023 DBMET00640 | DBMET00640 | |
| 0.011 | 0.467 | 0.167 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.167 0.004 DBMET00640 | DBMET00640 | |
| 0.002 | 0.46 | 0.031 | Uridine phosphorylase inhibitor | 0.031 0.017 DBMET00640 | DBMET00640 | |
| 0.064 | 0.524 | 0.235 | RNA-directed DNA polymerase inhibitor | 0.235 0.06 DBMET00640 | DBMET00640 | |
| 0.009 | 0.47 | 0.073 | Alpha-mannosidase inhibitor | 0.073 0.015 DBMET00640 | DBMET00640 | |
| 0.006 | 0.47 | 0.077 | Alcohol oxidase inhibitor | 0.077 0.025 DBMET00640 | DBMET00640 | |
| 0.004 | 0.475 | 0.029 | Calcium-sensing receptor agonist | 0.029 0.014 DBMET00640 | DBMET00640 | |
| 0.008 | 0.483 | 0.071 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.071 0.025 DBMET00640 | DBMET00640 | |
| 0.006 | 0.483 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET00640 | DBMET00640 | |
| 0.004 | 0.482 | 0.041 | Dopamine D5 agonist | 0.041 0.027 DBMET00640 | DBMET00640 | |
| 0.031 | 0.52 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.073 DBMET00640 | DBMET00640 | |
| 0.013 | 0.502 | 0.098 | Glycine receptor antagonist | 0.098 0.034 DBMET00640 | DBMET00640 | |
| 0.053 | 0.543 | 0.206 | Histamine release inhibitor | 0.206 0.195 DBMET00640 | DBMET00640 | |
| 0.016 | 0.508 | 0.164 | Cyclooxygenase 2 inhibitor | 0.164 0.045 DBMET00640 | DBMET00640 | |
| 0.018 | 0.513 | 0.109 | Alkaline phosphatase inhibitor | 0.109 0.101 DBMET00640 | DBMET00640 | |
| 0.029 | 0.527 | 0.091 | Phosphodiesterase 6D inhibitor | 0.091 0.072 DBMET00640 | DBMET00640 | |
| 0.005 | 0.508 | 0.079 | Acyl-CoA dehydrogenase inhibitor | 0.079 0.023 DBMET00640 | DBMET00640 | |
| 0.012 | 0.523 | 0.075 | Heparanase inhibitor | 0.075 0.008 DBMET00640 | DBMET00640 | |
| 0.028 | 0.543 | 0.416 | Aldehyde oxidase inhibitor | 0.416 0.045 DBMET00640 | DBMET00640 | |
| 0.01 | 0.532 | 0.053 | Kainate receptor agonist | 0.053 0.011 DBMET00640 | DBMET00640 | |
| 0.01 | 0.534 | 0.082 | Aminopeptidase I inhibitor | 0.082 0.04 DBMET00640 | DBMET00640 | |
| 0.017 | 0.541 | 0.145 | Carbonic anhydrase II stimulant | 0.145 0.003 DBMET00640 | DBMET00640 | |
| 0.022 | 0.546 | 0.665 | Dual specificity phosphatase inhibitor | 0.665 0.004 DBMET00640 | DBMET00640 | |
| 0.007 | 0.532 | 0.094 | Catalase inhibitor | 0.094 0.041 DBMET00640 | DBMET00640 | |
| 0.001 | 0.526 | 0.019 | Aminopeptidase A inhibitor | 0.019 0.012 DBMET00640 | DBMET00640 | |
| 0.027 | 0.554 | 0.119 | Photosensitizer | 0.119 0.059 DBMET00640 | DBMET00640 | |
| 0.019 | 0.548 | 0.288 | Anticoagulant | 0.288 0.03 DBMET00640 | DBMET00640 | |
| 0.006 | 0.54 | 0.178 | Carbamoyl phosphate synthetase inhibitor | 0.178 0.009 DBMET00640 | DBMET00640 | |
| 0.038 | 0.579 | 0.15 | CF transmembrane conductance regulator agonist | 0.15 0.076 DBMET00640 | DBMET00640 | |
| 0.017 | 0.56 | 0.139 | Cyclooxygenase inhibitor | 0.139 0.079 DBMET00640 | DBMET00640 | |
| 0.001 | 0.547 | 0.016 | Telomerase stimulant | 0.016 0.015 DBMET00640 | DBMET00640 | |
| 0.015 | 0.561 | 0.101 | Purinergic P2X1 antagonist | 0.101 0.016 DBMET00640 | DBMET00640 | |
| 0.001 | 0.558 | 0.024 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.024 0.023 DBMET00640 | DBMET00640 | |
| 0.03 | 0.602 | 0.187 | DNA damaging | 0.187 0.126 DBMET00640 | DBMET00640 | |
| 0.004 | 0.585 | 0.024 | Vanilloid 2 agonist | 0.024 0.021 DBMET00640 | DBMET00640 | |
| 0.016 | 0.598 | 0.192 | Arachidonic acid antagonist | 0.192 0.04 DBMET00640 | DBMET00640 | |
| 0.013 | 0.597 | 0.063 | Dihydroorotate oxidase inhibitor | 0.063 0.024 DBMET00640 | DBMET00640 | |
| 0.051 | 0.644 | 0.396 | GABA C receptor rho-3 antagonist | 0.396 0.063 DBMET00640 | DBMET00640 | |
| 0.01 | 0.608 | 0.111 | Mucolytic | 0.111 0.064 DBMET00640 | DBMET00640 | |
| 0.07 | 0.67 | 0.135 | Heat shock protein 70 antagonist | 0.135 0.095 DBMET00640 | DBMET00640 | |
| 0.02 | 0.619 | 0.085 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.062 DBMET00640 | DBMET00640 | |
| 0.021 | 0.623 | 0.269 | Succinate dehydrogenase inhibitor | 0.269 0.017 DBMET00640 | DBMET00640 | |
| 0.028 | 0.637 | 0.165 | Phospholipase C inhibitor | 0.165 0.08 DBMET00640 | DBMET00640 | |
| 0.001 | 0.61 | 0.023 | Ileal bile acid transport inhibitor | 0.023 0.007 DBMET00640 | DBMET00640 | |
| 0.001 | 0.617 | 0.024 | Carbonic anhydrase XI inhibitor | 0.024 0.003 DBMET00640 | DBMET00640 | |
| 0.014 | 0.633 | 0.696 | Dual specificity phosphatase 3 inhibitor | 0.696 0.003 DBMET00640 | DBMET00640 | |
| 0.012 | 0.633 | 0.086 | GABA B receptor agonist | 0.086 0.031 DBMET00640 | DBMET00640 | |
| 0.002 | 0.627 | 0.962 | Estrone sulfatase inhibitor | 0.962 0 DBMET00640 | DBMET00640 | |
| 0.002 | 0.631 | 0.025 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.025 0.014 DBMET00640 | DBMET00640 | |
| 0.012 | 0.642 | 0.14 | Sphingosine 1-phosphate receptor 2 antagonist | 0.14 0.055 DBMET00640 | DBMET00640 | |
| 0.007 | 0.641 | 0.083 | NMDA receptor agonist | 0.083 0.027 DBMET00640 | DBMET00640 | |
| 0.004 | 0.639 | 0.055 | Estrogen agonist | 0.055 0.032 DBMET00640 | DBMET00640 | |
| 0.004 | 0.639 | 0.054 | NMDA receptor glycine site agonist | 0.054 0.053 DBMET00640 | DBMET00640 | |
| 0.005 | 0.641 | 0.045 | Membrane dipeptidase inhibitor | 0.045 0.021 DBMET00640 | DBMET00640 | |
| 0.056 | 0.693 | 0.271 | Tyrosine 3 hydroxylase inhibitor | 0.271 0.051 DBMET00640 | DBMET00640 | |
| 0.005 | 0.644 | 0.4 | Protein-tyrosine phosphatase 1B inhibitor | 0.4 0.005 DBMET00640 | DBMET00640 | |
| 0.004 | 0.646 | 0.091 | Na+ K+ transporting ATPase inhibitor | 0.091 0.04 DBMET00640 | DBMET00640 | |
| 0.002 | 0.647 | 0.197 | Carbonic anhydrase XII inhibitor | 0.197 0.009 DBMET00640 | DBMET00640 | |
| 0.044 | 0.689 | 0.394 | Sodium/bile acid cotransporter inhibitor | 0.394 0.019 DBMET00640 | DBMET00640 | |
| 0.021 | 0.666 | 0.417 | Peroxidase inhibitor | 0.417 0.018 DBMET00640 | DBMET00640 | |
| 0.002 | 0.651 | 0.061 | Dihydropteroate synthase inhibitor | 0.061 0.011 DBMET00640 | DBMET00640 | |
| 0.015 | 0.666 | 0.154 | Electrolyte absorption antagonist | 0.154 0.018 DBMET00640 | DBMET00640 | |
| 0.006 | 0.658 | 0.104 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.104 0.011 DBMET00640 | DBMET00640 | |
| 0.022 | 0.676 | 0.148 | GABA C receptor rho-2 antagonist | 0.148 0.076 DBMET00640 | DBMET00640 | |
| 0.03 | 0.684 | 0.281 | Superoxide dismutase inhibitor | 0.281 0.058 DBMET00640 | DBMET00640 | |
| 0.003 | 0.657 | 0.081 | Aromatase inhibitor | 0.081 0.027 DBMET00640 | DBMET00640 | |
| 0.03 | 0.685 | 0.246 | Gastrin inhibitor | 0.246 0.084 DBMET00640 | DBMET00640 | |
| 0.019 | 0.675 | 0.434 | Carbonic anhydrase XV inhibitor | 0.434 0.004 DBMET00640 | DBMET00640 | |
| 0.003 | 0.66 | 0.373 | Carbonic anhydrase VII inhibitor | 0.373 0.003 DBMET00640 | DBMET00640 | |
| 0.014 | 0.675 | 0.112 | Interleukin 8 antagonist | 0.112 0.073 DBMET00640 | DBMET00640 | |
| 0.002 | 0.662 | 0.017 | Purinergic P2Y1 agonist | 0.017 0.009 DBMET00640 | DBMET00640 | |
| 0.074 | 0.736 | 0.207 | 5 Hydroxytryptamine 3E antagonist | 0.207 0.052 DBMET00640 | DBMET00640 | |
| 0.002 | 0.665 | 0.038 | Phosphoglycerate kinase inhibitor | 0.038 0.021 DBMET00640 | DBMET00640 | |
| 0.003 | 0.666 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.018 DBMET00640 | DBMET00640 | |
| 0.007 | 0.672 | 0.13 | Carbonic anhydrase stimulant | 0.13 0.013 DBMET00640 | DBMET00640 | |
| 0.013 | 0.68 | 0.13 | Cathepsin H inhibitor | 0.13 0.063 DBMET00640 | DBMET00640 | |
| 0.025 | 0.702 | 0.489 | Cholesterol antagonist | 0.489 0.034 DBMET00640 | DBMET00640 | |
| 0.002 | 0.682 | 0.038 | Estradiol 17 beta-dehydrogenase inhibitor | 0.038 0.033 DBMET00640 | DBMET00640 | |
| 0.045 | 0.726 | 0.304 | Calcium channel activator | 0.304 0.088 DBMET00640 | DBMET00640 | |
| 0.013 | 0.695 | 0.12 | Anabolic | 0.12 0.04 DBMET00640 | DBMET00640 | |
| 0.008 | 0.7 | 0.092 | Glucose-6-phosphate isomerase inhibitor | 0.092 0.006 DBMET00640 | DBMET00640 | |
| 0.002 | 0.696 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.024 0.012 DBMET00640 | DBMET00640 | |
| 0.03 | 0.727 | 0.211 | Insulysin inhibitor | 0.211 0.141 DBMET00640 | DBMET00640 | |
| 0.009 | 0.717 | 0.044 | CC chemokine 4 receptor antagonist | 0.044 0.038 DBMET00640 | DBMET00640 | |
| 0.002 | 0.71 | 0.39 | Carbonic anhydrase IX inhibitor | 0.39 0.004 DBMET00640 | DBMET00640 | |
| 0.014 | 0.726 | 0.072 | Vanilloid 4 agonist | 0.072 0.058 DBMET00640 | DBMET00640 | |
| 0.012 | 0.728 | 0.688 | Carbonic anhydrase VI inhibitor | 0.688 0.002 DBMET00640 | DBMET00640 | |
| 0 | 0.721 | 0.032 | Carbonic anhydrase X inhibitor | 0.032 0.004 DBMET00640 | DBMET00640 | |
| 0 | 0.721 | 0.032 | Carbonic anhydrase VIII inhibitor | 0.032 0.004 DBMET00640 | DBMET00640 | |
| 0.008 | 0.729 | 0.125 | Microtubule formation inhibitor | 0.125 0.056 DBMET00640 | DBMET00640 | |
| 0.005 | 0.727 | 0.312 | Tubulin antagonist | 0.312 0.018 DBMET00640 | DBMET00640 | |
| 0.002 | 0.73 | 0.471 | Carbonic anhydrase VB inhibitor | 0.471 0.002 DBMET00640 | DBMET00640 | |
| 0.014 | 0.743 | 0.433 | Carbonic anhydrase III inhibitor | 0.433 0.004 DBMET00640 | DBMET00640 | |
| 0.004 | 0.738 | 0.175 | Alkylator | 0.175 0.035 DBMET00640 | DBMET00640 | |
| 0.002 | 0.74 | 0.35 | Carbonic anhydrase I inhibitor | 0.35 0.004 DBMET00640 | DBMET00640 | |
| 0.028 | 0.766 | 0.083 | CC chemokine 5 receptor agonist | 0.083 0.055 DBMET00640 | DBMET00640 | |
| 0.014 | 0.76 | 0.316 | Antithrombotic | 0.316 0.079 DBMET00640 | DBMET00640 | |
| 0.006 | 0.756 | 0.062 | Interferon inducer | 0.062 0.049 DBMET00640 | DBMET00640 | |
| 0.013 | 0.763 | 0.173 | Adenylate cyclase stimulant | 0.173 0.032 DBMET00640 | DBMET00640 | |
| 0.003 | 0.761 | 0.165 | Carbonic anhydrase XIV inhibitor | 0.165 0.005 DBMET00640 | DBMET00640 | |
| 0.001 | 0.767 | 0.185 | Carbonic anhydrase IV inhibitor | 0.185 0.003 DBMET00640 | DBMET00640 | |
| 0.002 | 0.769 | 0.35 | Carbonic anhydrase II inhibitor | 0.35 0.004 DBMET00640 | DBMET00640 | |
| 0.002 | 0.773 | 0.418 | Carbonic anhydrase inhibitor | 0.418 0.004 DBMET00640 | DBMET00640 | |
| 0.003 | 0.777 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | 0.053 0.031 DBMET00640 | DBMET00640 | |
| 0.004 | 0.778 | 0.213 | Carbonic anhydrase VA inhibitor | 0.213 0.004 DBMET00640 | DBMET00640 | |
| 0.005 | 0.784 | 0.071 | Interferon agonist | 0.071 0.068 DBMET00640 | DBMET00640 | |
| 0.004 | 0.789 | 0.128 | Phospholipase A2 inhibitor | 0.128 0.104 DBMET00640 | DBMET00640 | |
| 0.003 | 0.791 | 0.478 | Carbonic anhydrase V inhibitor | 0.478 0.003 DBMET00640 | DBMET00640 | |
| 0.018 | 0.814 | 0.078 | Estrogen-related receptor beta agonist | 0.078 0.075 DBMET00640 | DBMET00640 | |
| 0.007 | 0.803 | 0.248 | Antimitotic | 0.248 0.06 DBMET00640 | DBMET00640 | |
| 0.004 | 0.801 | 0.15 | Diuretic | 0.15 0.077 DBMET00640 | DBMET00640 | |
| 0.006 | 0.819 | 0.331 | Carbonic anhydrase XIII inhibitor | 0.331 0.005 DBMET00640 | DBMET00640 | |
| 0.002 | 0.82 | 0.049 | Factor Xa inhibitor | 0.049 0.03 DBMET00640 | DBMET00640 | |
| 0.004 | 0.838 | 0.054 | Purinergic P2X4 antagonist | 0.054 0.02 DBMET00640 | DBMET00640 | |
| 0.004 | 0.852 | 0.034 | Follicle-stimulating hormone antagonist | 0.034 0.004 DBMET00640 | DBMET00640 | |
| 0.002 | 0.923 | 0.096 | Urotensin II antagonist | 0.096 0.005 DBMET00640 | DBMET00640 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |